Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine ; volume:20 ; number:1 ; day:29 ; month:9 ; year:2021 ; pages:1-13 ; date:12.2021
Molecular cancer ; 20, Heft 1 (29.9.2021), 1-13, 12.2021
- Urheber
-
Pamarthy, Sahithi
Sabaawy, Hatem E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-021-01426-3
- URN
-
urn:nbn:de:101:1-2021121819212570094529
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pamarthy, Sahithi
- Sabaawy, Hatem E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Breast cancer organoids and their applications for precision cancer immunotherapy
Patient derived organoids to model rare prostate cancer phenotypes
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Precision therapeutic targets for COVID-19
Prostate cancer and therapeutic challenges
Applications of lung cancer organoids in precision medicine: from bench to bedside
Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
Urological cancer organoids, patients' avatars for precision medicine: past, present and future
Improving ultrasound-based prostate volume estimation
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Improving the feasibility of precision-oriented HPSG parsing
Improving the pointing precision of the H.E.S.S. experiment
Breast cancer organoids and their applications for precision cancer immunotherapy
Patient derived organoids to model rare prostate cancer phenotypes
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Precision therapeutic targets for COVID-19
Prostate cancer and therapeutic challenges
Applications of lung cancer organoids in precision medicine: from bench to bedside
Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
Urological cancer organoids, patients' avatars for precision medicine: past, present and future
Improving ultrasound-based prostate volume estimation
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Improving the feasibility of precision-oriented HPSG parsing
Improving the pointing precision of the H.E.S.S. experiment
Breast cancer organoids and their applications for precision cancer immunotherapy
Patient derived organoids to model rare prostate cancer phenotypes
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Precision therapeutic targets for COVID-19
Prostate cancer and therapeutic challenges
Applications of lung cancer organoids in precision medicine: from bench to bedside
Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
Urological cancer organoids, patients' avatars for precision medicine: past, present and future
Improving ultrasound-based prostate volume estimation
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Improving the feasibility of precision-oriented HPSG parsing